NCT07654452

Brief Summary

This randomized comparative clinical trial aims to evaluate the clinical, radiographic, and esthetic outcomes of flap versus flapless techniques for delayed dental implant placement in the maxillary esthetic zone. Sixteen patients requiring implant placement in the maxillary anterior or premolar region will be randomly allocated into two equal groups. Group I will undergo implant placement using the conventional flap technique, while Group II will receive implant placement using the flapless technique. Clinical outcomes including postoperative pain, edema, surgical insertion time, and implant stability will be assessed. Radiographic evaluation will include peri-implant bone quantity, bone quality, and crestal bone loss. Follow-up examinations will be performed immediately after surgery and at 1, 3 and 6 months postoperatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

1.2 years

First QC Date

June 12, 2026

Last Update Submit

June 12, 2026

Conditions

Keywords

Dental ImplantFlapless Implant SurgeryFlap TechniqueDental Implant StabilityMarginal Bone Loss

Outcome Measures

Primary Outcomes (3)

  • Implant Stability Quotient (ISQ)

    Implant stability measured using the Osstell resonance frequency analysis device.

    Immediately after implant placement and 6 months postoperatively.

  • Marginal Crestal Bone Loss

    Radiographic assessment of peri-implant crestal bone level changes using standardized digital periapical radiographs.

    Immediately postoperative, 1 month, 3 months, and 6 months.

  • Relative bone density

    Radiographic assessment of peri-implant bone density using standardized digital periapical radiographs.

    Immediately postoperative, 1 month, 3 months, and 6 months.

Secondary Outcomes (4)

  • Postoperative Pain

    Postoperative days 1, 3, and 7.

  • Postoperative Edema

    Postoperative days 1,3 and 7.

  • Surgical Insertion Time

    During surgery.

  • Postoperative Comfort

    1 day postoperatively

Study Arms (2)

Flap Technique

EXPERIMENTAL

Delayed implant placement using a conventional full-thickness mucoperiosteal flap approach.

Procedure: Flap Implant Placement

Flapless Technique

EXPERIMENTAL

Delayed implant placement using a flapless surgical approach.

Procedure: Flapless Implant Placement

Interventions

Implant placement following crestal incision and mucoperiosteal flap elevation to expose the alveolar ridge.

Flap Technique

Implant placement performed without flap elevation using a minimally invasive flapless approach.

Flapless Technique

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged from 30 to 50 years old.
  • Adults of both genders.
  • Patients who are free from any systemic disease (ASA I).
  • Patients with teeth loss at upper anterior and premolar regions more than 1-year.
  • Presence of sufficient apical and peripheral bone to achieve primary implant stability (minimum 3-5 mm of bone beyond the socket apex and overall socket length ≥ 10 mm).
  • Patients with bone quality classified as D3, as assessed by pre-operative CBCT.

You may not qualify if:

  • Pregnant and lactating women.
  • Heavy smoking (\>10 cigarettes/day)
  • Patients with bad oral habits such as bruxism.
  • Patients with poor oral hygiene.
  • Patients with gingival diseases.
  • Patients with periodontal diseases (with severe vertical or horizontal bone loss).
  • Teeth with periapical or lateral infection or lesions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University, Faculty of Dentistry

Ismailia, Egypt

Location

MeSH Terms

Conditions

Tooth Loss

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesTooth Diseases

Study Officials

  • Mohamed Said Hamed, Professor of Oral and Maxillof

    Suez Canal University

    STUDY CHAIR
  • Ahmed Abdelmohsen Younis, Associate Professor of Oral an

    Suez Canal University

    STUDY DIRECTOR
  • Mina Raafat, B.S.D

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned into two parallel groups. One group will receive delayed implant placement using the conventional flap technique, while the second group will receive delayed implant placement using the flapless technique.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 12, 2026

First Posted

June 17, 2026

Study Start

January 10, 2025

Primary Completion

April 10, 2026

Study Completion

May 10, 2026

Last Updated

June 17, 2026

Record last verified: 2026-06

Locations